EUVIMEDObjevte EUVIMED
Vergleichsstudie

Assessment of atherectomy treatment for Thromboangiitis Obliterans: A single center experience

Song Xue, Xing Zhang, Zhaoxi Peng, Xiaoyu Wu, Zhiyou Peng, Jinbao Qin, Xinwu Lu iD

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30801 ↗

At a glance

Vergleichsstudie in Catheterization and Cardiovascular Interventions, 2023. Written by Song Xue and 6 co-authors. Institution: Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai, China. Major MEDLINE topics: Thromboangiitis Obliterans, Atherectomy. Cited 1 times so far (Crossref); 37 references. Funded by: Science and Technology Commission of Shanghai Municipality, Shanghai Sailing Program.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Aims Endovascular recanalizaiton (ER) has been proven to be a feasible method for Thromboangiitis Obliterans (TAO). The aims of this study were to evaluate the effectiveness and safety of atherectomy for TAO compared to nonatherectomy ER in our center.

Methods

Patients diagnosed as TAO were reviewed from January 2016 to June 2021 in our center. Basic characteristics of patients before ER and perioperative data were collected and compared between the atherectomy and nonatherectomy groups. The vascular event‐free survival and limb salvage were calculated to evaluate the prognosis of TAO patients after ERs. Logistic Regression and Cox Regression were used to identify the risk factors for technical failure and prognosis, respectively.

Results

Seventy‐two TAO patients with 79 lower limbs who met the criteria were included in this report. Compared with the nonatherectomy group, no significant improvement was identified in ER technical success, vascular event‐free survival, or limb salvage in the atherectomy group. The total technical success rate was 91.1% (atherectomy group, 95.2%; nonatherectomy group, 89.7%), and the multiple limb involvement ( p = 0.005; odds ratio [OR], 28.16; confidence interval [CI], 3.28−241.55) was the independent risk factor for technical failure. The total vascular event‐free survival proportion was 66.05% and 58.40% at 1 and 3 years, respectively. Technical failure (OR, 5.61; 95% CI, 1.57−20.04; p = 0.008), and runoff grade 0 (OR, 3.28; 95% CI, 1.09−9.85; p = 0.034) were independent risk factors for vascular events. The total limb salvage proportion at 1 and 3 years was 95.84% and 92.53%, respectively. Technical failure (OR, 8.54; 95% CI, 1.71−40.73; p = 0.02) was identified as an independent risk factor for above ankle amputation.

Conclusions

No significant difference in prognosis was found between the atherectomy group and the nonatherectomy group during a midterm follow‐up. The technical success of ER was crucial for TAO prognosis.

Subjects

MeSH terms (MEDLINE)

Thromboangiitis ObliteransAtherectomyHumansMaleFemaleMiddle AgedLimb SalvageRetrospective StudiesRisk FactorsTime FactorsAgedVascular PatencyProgression-Free SurvivalRisk AssessmentAdultTreatment OutcomeAmputation, Surgical

Author keywords

Thromboangiitis Obliteransatherectomyendovascular therapy

Authors and institutions

  • Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai, China.

ORCID profiles: Xinwu Lu

Funding

  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Sailing Program

Cite

APA

Xue, S., Zhang, X., Peng, Z., Wu, X., Peng, Z., Qin, J., & Lu, X. (2023). Assessment of atherectomy treatment for Thromboangiitis Obliterans: A single center experience. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30801

Vancouver

Xue S, Zhang X, Peng Z, Wu X, Peng Z, Qin J, et al. Assessment of atherectomy treatment for Thromboangiitis Obliterans: A single center experience. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30801

BibTeX
@article{Xue2023,
  author = {Xue, Song and Zhang, Xing and Peng, Zhaoxi and Wu, Xiaoyu and Peng, Zhiyou and Qin, Jinbao and Lu, Xinwu},
  title = {Assessment of atherectomy treatment for Thromboangiitis Obliterans: A single center experience},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30801}
}
Start for free →